MindBio Announces Proposed Issuance of Listed Securities
Vancouver, British Columbia – TheNewswire – October 16, 2024 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6), (the “Company” or “MindBio”), a leading biopharmaceutical company in psychiatric medicine...
Read More